Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Operating Expenses Summary of Medtecs International Corporation Limited

  • Medtecs International Corporation Limited's latest annual operating expenses in 2023 was 5.95 Million USD , up 4.87% from previous year.
  • Medtecs International Corporation Limited's latest quarterly operating expenses in 2024 Q2 was 9.3 Million USD , down -52.77% from previous quarter.
  • Medtecs International Corporation Limited reported a annual operating expenses of 29.1 Million USD in annual operating expenses 2022, up 14.92% from previous year.
  • Medtecs International Corporation Limited reported a annual operating expenses of 25.32 Million USD in annual operating expenses 2021, down -28.01% from previous year.
  • Medtecs International Corporation Limited reported a quarterly operating expenses of 30.51 Million USD for 2023 FY, up 4.87% from previous quarter.
  • Medtecs International Corporation Limited reported a quarterly operating expenses of 10.3 Million USD for 2023 Q2, down -29.64% from previous quarter.

Annual Operating Expenses Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Operating Expenses of Medtecs International Corporation Limited (2023 - 2009)

Year Operating Expenses Operating Expenses Growth
2023 5.95 Million USD 4.87%
2022 29.1 Million USD 14.92%
2021 25.32 Million USD -28.01%
2020 35.17 Million USD 369.28%
2019 7.49 Million USD -2.14%
2018 7.66 Million USD 6.23%
2017 7.21 Million USD 10.21%
2016 6.54 Million USD -3.01%
2015 6.74 Million USD 10.57%
2014 6.1 Million USD -10.71%
2013 6.83 Million USD -5.26%
2012 7.21 Million USD -5.44%
2011 7.62 Million USD -14.32%
2010 8.9 Million USD -7.91%
2009 9.66 Million USD 0.0%

Peer Operating Expenses Comparison of Medtecs International Corporation Limited

Name Operating Expenses Operating Expenses Difference
Nang Kuang Pharmaceutical Co., Ltd. 495.65 Million TWD 98.798%
Maxigen Biotech Inc. 274.24 Million TWD 97.828%
SciVision Biotech Inc. 312.85 Million TWD 98.096%
Bionime Corporation 673.63 Million TWD 99.116%
Pegavision Corporation 1.68 Billion TWD 99.647%
Visco Vision Inc. 522.44 Million TWD 98.86%